ADAP - Adaptimmune Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts5555
Avg. Estimate-0.31-0.31-1.17-1.14
Low Estimate-0.35-0.35-1.34-1.45
High Estimate-0.27-0.28-0.94-0.9
Year Ago EPS-0.480.06-0.96-1.17
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts7777
Avg. Estimate1.36M1.14M6.76M12.6M
Low EstimateN/AN/AN/AN/A
High Estimate3M3M20M36M
Year Ago Sales9.04M40.79M59.51M6.76M
Sales Growth (year/est)-85.00%-97.20%-88.60%86.40%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.27-0.06-0.32-0.31
EPS Actual-0.480.06-0.36-0.26
Difference-0.210.12-0.040.05
Surprise %-77.80%200.00%-12.50%16.10%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.31-0.31-1.17-1.14
7 Days Ago-0.31-0.31-1.17-1.14
30 Days Ago-0.31-0.31-1.2-1.19
60 Days Ago-0.31-0.31-1.21-1.15
90 Days Ago-0.32-0.32-1.21-1.15
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days2221
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/A11
Growth EstimatesADAPIndustrySectorS&P 500
Current Qtr.35.40%N/AN/A0.02
Next Qtr.-616.70%N/AN/A0.04
Current Year-21.90%N/AN/A0.05
Next Year2.60%N/AN/A0.10
Next 5 Years (per annum)1.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A